Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 320 participants.
Also called NCT07768631
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 320 participants
- Sponsor
- Endogenex, Inc.
- Registry
-
NCT07768631
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07768631. Randomized; double masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2029-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
- Acronym
- pulsENDO
- Condition
- Diabetes Type 2
- Condition
- Diabetes
- Condition
- Diabetes (DM)
- Condition
- Weight Change
- Condition
- Glycemic Control
- Condition
- Glycemic Control for Diabetes Mellitus
- Intervention (Device)
- pulsENDO Therapy
- Lead sponsor
- Endogenex, Inc.
Record details
- Record id
cardio:ct-nct07768631- Content hash
d9a075e1a7e476d98c70f2df65c5a769e19ba553ca0f68f330ae88e66d520a73